News

Survey spotlights the concern levels associated with the adoption of clinical trials using wearable technology.

Study shows sharp reduction in market exclusivity periods for first-in-class treatment entrants.

Search-engine data offers window to public consciousness around clinical trial research, participation.

This three-step process can help managers accurately assess how patient-centric their trials really are.

Despite wealth of data collected, many inefficiencies exist in the site-sponsor transfer of insights from clinical trials.

Analysis of the largest antihypertensive trial ever offers useful blueprint for sites in boosting subject enrollment.

Survey takes deep dive into enrollment hurdles, aims to inform future recommendations for improvement.

Measuring clinically relevant response requires routine and regular collection of outcomes data.

Click the title above to open the Applied Clinical Trials February/March 2016 issue in an interactive PDF format.

Oracle will participate as a Global Impact Partner (GIP) and will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.

Bioclinica has built a post-approval study-specific technology platform along with a Program Coordinating Center (PCC) with dedicated and experienced post-approval research staff.

The alliance’s primary goal is to be flexible and adaptive based on client needs, while mitigating client risk, driving efficiency and improving timelines, and removing barriers that prevent getting treatments to market in a timely fashion.

A "can’t live with them, can’t live without them" attitude is revealed in survey of standard operating procedures in the management and conduct of clinical trials.

In addition to the patient education database, guidelines for the interaction of patient organizations with ethics, health technology assessment, regulatory bodies and industry are being developed with the goal of being released later in the year.

Gather™ is an integrated technology system that can be accessed through any internet-connected device and uses a module-based product suite.

New approaches include using Big Data to identify and understand patient populations, engaging the “voice of the patient” in trial design, and using new technologies and social media to reach, attract, and keep patients.

Clinerion will present its Patient Recruitment System (PRS), which allows real-time patient search for clinical trials via direct query of electronic health records.

FDA will provide expert scientific, clinical and statistical input to guide the further enhancement of CCDA to support FDA reviewers in rapidly detecting and investigating safety signals during new drug application (NDA) reviews and post-market pharmacovigilance activities.